GlaxoSmithKline Urges Kenya to Crackdown on Imports of Fake Medicines

by Medindia Content Team on  April 15, 2008 at 2:32 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

British pharmaceuticals giant GlaxoSmithKline, urged the Kenyan government on Monday to block imports of fake medicines, that account for a third of the country's drugs trade.
GlaxoSmithKline Urges Kenya to Crackdown on Imports of Fake Medicines
GlaxoSmithKline Urges Kenya to Crackdown on Imports of Fake Medicines

GSK's east Africa chief John Musunga said although his firm had no problem with parallel trade -- importation of cheaper products with the intent of charging less than the competitors in the retail market -- the authorities should tight crackdowns.

"There is no contention there, but unfortunately most of those mechanisms lead to the importation of more counterfeits than genuine ones," Musunga told reporters.

He explained that such trade arrangements compromise conditions under which specialised drugs are meant to be transported, leading to the sale of sub-standard products.

"Exposing medicines to high temperatures or unfavourable conditions changes the composition of the drugs, rendering them ineffective," added Musunga, whose Nairobi firm serves nine African nations.

Counterfeit drugs account for 30 percent of the pharmaceutical trade in the east African nation.

Source: AFP
THK/L

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive